急性冠状动脉综合征二级预防临床试验的未来。 - Suppr

The future of clinical trials in secondary prevention after acute coronary syndromes.

作者信息

Bueno Héctor, Armstrong Paul W, Buxton Martin J, Danchin Nicolas, Lubsen Jacobus, Roland Edmond, Verheugt Freek W, Zalewski Andrew, Jackson Neville, Komajda Michel, Steg Ph Gabriel

机构信息

Department of Cardiology, Hospital General Universitario Gregorio Marañón, Dr. Esquerdo 46, Madrid, Spain.

出版信息

Eur Heart J. 2011 Jul;32(13):1583-9. doi: 10.1093/eurheartj/ehq388. Epub 2010 Oct 29.

DOI:10.1093/eurheartj/ehq388

PMID:21037255

Abstract

摘要

相似文献

The future of clinical trials in secondary prevention after acute coronary syndromes.

Eur Heart J. 2011 Jul;32(13):1583-9. doi: 10.1093/eurheartj/ehq388. Epub 2010 Oct 29.

[Design of clinical studies: new approaches beyond randomised investigations].

Dtsch Med Wochenschr. 2014 Sep;139(39):1921-2. doi: 10.1055/s-0034-1387251. Epub 2014 Sep 16.

Rivaroxaban in acute coronary syndromes: too soon to know?

Lancet. 2009 Jul 4;374(9683):3-4. doi: 10.1016/S0140-6736(09)60952-1. Epub 2009 Jun 17.

The value of clinical wisdom in randomised studies, real-world registries and new hypotheses.

J Cardiovasc Med (Hagerstown). 2007 May;8(5):313-7. doi: 10.2459/JCM.0b013e32813e4024.

Comparing outcomes on peritoneal and hemodialysis: a case study in the interpretation of observational studies.

Saudi J Kidney Dis Transpl. 2007 Mar;18(1):24-30.

Acute coronary syndromes in the elderly.

J Cardiovasc Med (Hagerstown). 2011 Mar;12(3):220-2. doi: 10.2459/JCM.0b013e328343e9ce.

Stenting the coronaries and bypassing the evidence in patients with multivessel coronary artery disease: time to set the record straight.

J Cardiovasc Med (Hagerstown). 2007 May;8(5):362-70. doi: 10.2459/JCM.0b013e32807fb088.

High risk and unfit for open repair are not the same.

Eur J Vasc Endovasc Surg. 2007 Aug;34(2):154-5. doi: 10.1016/j.ejvs.2007.04.006. Epub 2007 Jun 18.

Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries.

Clin Ther. 2008;30 Pt 2:2191-202. doi: 10.1016/j.clinthera.2008.12.001.

Design of randomized controlled trials.

Circulation. 2007 Mar 6;115(9):1164-9. doi: 10.1161/CIRCULATIONAHA.105.594945.

引用本文的文献

Sedentary Behavior and Cardiac Events and Mortality After Hospitalization for Acute Coronary Syndrome Symptoms: A Prospective Study.

Circ Cardiovasc Qual Outcomes. 2025 Jun;18(6):e011644. doi: 10.1161/CIRCOUTCOMES.124.011644. Epub 2025 May 19.

Participation in disease management programs and major adverse cardiac events in patients after acute myocardial infarction: a longitudinal study based on registry data.

BMC Cardiovasc Disord. 2021 Jan 6;21(1):18. doi: 10.1186/s12872-020-01832-3.

Design and rationale of the Danish trial of beta-blocker treatment after myocardial infarction without reduced ejection fraction: study protocol for a randomized controlled trial.

Trials. 2020 May 23;21(1):415. doi: 10.1186/s13063-020-4214-6.

MicroRNAs as Prognostic Markers in Acute Coronary Syndrome Patients-A Systematic Review.

Cells. 2019 Dec 4;8(12):1572. doi: 10.3390/cells8121572.

Bin-CE: A comprehensive web application to decide upon the best set of outcomes to be combined in a binary composite endpoint.

PLoS One. 2018 Dec 13;13(12):e0209000. doi: 10.1371/journal.pone.0209000. eCollection 2018.

Individual and composite study endpoints: separating the wheat from the chaff.

Am J Med. 2014 May;127(5):379-84. doi: 10.1016/j.amjmed.2014.01.011. Epub 2014 Jan 28.

Rationale, design and methods of CTCA-PRORECAD (Computed Tomography Coronary Angiography Prognostic Registry for Coronary Artery Disease): a multicentre and multivendor registry.

Radiol Med. 2013 Jun;118(4):591-607. doi: 10.1007/s11547-012-0912-9. Epub 2013 Jan 28.

Secondary prevention following myocardial infarction--there is still more to be done.

Dtsch Arztebl Int. 2011 Dec;108(50):854. doi: 10.3238/arztebl.2011.0854. Epub 2011 Dec 16.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

The future of clinical trials in secondary prevention after acute coronary syndromes.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献